ロード中...
5‐aminolaevulinic acid/photo‐dynamic therapy and gefitinib in non‐small cell lung cancer cell lines: a potential strategy to improve gefitinib therapeutic efficacy
OBJECTIVES: Often, non‐small cell lung cancers (NSCLC) respond only poorly to the tyrosine kinase inhibitor (TKI) gefitinib, which targets the epidermal growth factor receptor (EGFR), these poor responders EGFRs lacking activating mutations. In this study, we have attempted to improve TKI response o...
保存先:
| 出版年: | Cell Prolif |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6622218/ https://ncbi.nlm.nih.gov/pubmed/23869760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12040 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|